[Comparative studies on the bioavailability of 2 amoxicillin preparations]

Area of Science:

• Pharmacology
• Drug Development

Background:

• Amoxicillin is a widely used antibiotic.
• Ensuring consistent therapeutic outcomes requires bioequivalent drug formulations.
• Regulatory approval necessitates demonstrating bioequivalence between generic and standard drugs.

Purpose of the Study:

• To assess the bioavailability of Sigamopen tablets, a new amoxicillin preparation.
• To compare the pharmacokinetic profile of Sigamopen against a standard amoxicillin formulation available in Germany.
• To establish bioequivalence between the test and standard amoxicillin preparations.

Main Methods:

• Administration of two amoxicillin preparations (Sigamopen tablets and a standard German product), each containing 750 mg.
• Measurement of serum concentrations over time.
• Analysis of pharmacokinetic parameters including bioavailability.
• Statistical comparison of data between the two preparations.

Main Results:

• No statistically significant differences were observed in serum amoxicillin concentrations between the two preparations.
• Bioavailability assessments indicated comparable drug absorption for both Sigamopen and the standard formulation.
• Key pharmacokinetic parameters, including Tmax and AUC, were similar for both tested amoxicillin products.

Conclusions:

• Sigamopen tablets are bioequivalent to the standard amoxicillin preparation.
• The findings support the interchangeability of Sigamopen with other amoxicillin formulations.
• The study results align with existing literature on amoxicillin bioavailability.